Introduction to the human gut microbiome
The human body can be thought of as a vehicle used by trillions of microscopic passengers. In fact, the number of prokaryotic cells associated with our bodies is on par numerically with our own number of eukaryotic cells [1] . The overall conglomeration of microbes making up the 'human microbiome' varies based on numerous factors including: diet, environment, and host genetics, among others [2, 3] . In the last two decades, there has been significant efforts by scientists to better understand this complex microbial community. Next generation nucleic acid sequencing, along with advances in both computational and bioinformatics analysis, has allowed for whole-genomic sequencing from both isolated bacterial strains in culture and those isolated via single-cell sorting. Reconstruction of individual genomes from complex microbial communities, and modeling bacterial metabolic potentials has allowed a greater understanding of their role in these ecosystems [4] [5] [6] . In tandem with these highthroughput analyses, the assignment of bacterial strains into operational taxonomic units (OTUs) is accomplished via comparison against 16S rRNA gene sequencing databases. The major bacterial phyla found in the human colon are the Firmicutes and Bacteroidetes which are Gram-positive and Gram-negative obligate anaerobes, respectively [4, 5] . Moreover, there are also significant number of bacterias belonging to the phylum Proteobacteria (Gram-negative facultative anaerobes) and Actinobacteria (Gram-positive facultative anaerobes) Fig. 1 [4, 5] . The utilization of OTU classification has important implications, as it is used to predict metabolic potential of complex microbial ecosystems. It is on the basis of OTU assignment that the observation was made that in spite of vast variation in microbial constituents, there is maintenance of metabolic potential across different individuals [3] .
The gut microbiota is viewed now as a 'virtual organ' [4] . Within this association between humans and microbes, a large amount of attention has been paid to the lumen of the large intestine. This anaerobic environment harbors the highest quantities (several hundred grams) and concentration (2-5 9 10 11 /g wet weight) of microbes in the human body. Moreover, the vast host gut mucosal layer allows for 'direct' interactions with the microbes and their metabolites. With possibly over 1000-species in our microbiome, the number of microbial genes eclipses our own by > 100-fold [7] . The 'human gut microbiome' refers to this highly diverse microbial ecosystem and under normal physiological conditions has a symbiotic relationship with the host. The gut microbiome plays important roles in producing energy sources for gut epithelial cell [8] , preventing colonization by harmful pathogens [9] and modulating host immunity [10] .
In the past, bile acids were viewed as mere detergents for nutrient acquisition by the host, and the profile of bile acids in germ-free animals differed markedly from conventional animals. In recent years, it has become widely accepted that bile acids are nutrient signaling hormone [11, 12] . Taken together, we can now describe gut microbial metabolism of bile acids as an important endocrine function of the gut microbiome. In this review, we will describe the latest developments in this rapidly expanding field. In particular, the identification of novel genes encoding bile acid metabolizing enzymes, as well as the role of the gut gas atmosphere on regulating bile acid biotransformations by specific gut bacteria. Short-chain fatty acid production in the large intestine
As with many niches in symbiotic ecosystems, there is usually an evolutionary 'opening' that allows for abundant but otherwise unused byproducts and nutrients to be exploited for energy production, respiration, or used for other cellular processes. The most quantitatively important example of this phenomenon in the large intestine is the plant-derived complex carbohydrates that escape absorption and metabolism in the small intestine. Hydrogen gas utilization by microbes in the large intestine H 2 producers are relatively abundant in the gut microbiota. Hydrogen production is common within the Firmicutes and Bacteroidetes phyla, the two major constituents colonizing the colon (Fig. 1) . A third mechanism of utilizing H 2 produced by gut microbial fermentation is through acetogenesis which is the pathway by which bacteria reduce CO 2 to acetate using molecular H 2 as the source of reducing equivalents. The study of acetogenesis takes its roots in the study of gas metabolism by anaerobic soil bacterium, as one of the first reports of this 'new type of glucose fermentation' was found in a strain of Clostridium thermoaceticum isolated from manure [37] . Subsequent studies by H. Wood and L. Ljungdahl elucidated an enzymatic pathway responsible for autotrophic synthesis of acetate from CO 2 known as the Wood-Ljungdahl pathway (WLP) [38] . The WLP is a multi-step enzymatic pathway that utilizes eight reducing equivalents and two CO 2 to form acetate Fig. 2 . The overall reaction yields even less energy than methanogenesis or sulfidogenesis, with a DG°0 = À95 kJÁmol À1 [29] . ATP is generated from ADP during the final substrate-level phosphorylation of acetyl-CoA to acetate. However, more recently it has been suggested that instead of acetogenesis being a pathway of energy production, it may be a means of regenerating oxidized pyridine nucleotides and Fd to maintain intracellular redox equilibrium [39] . Many acetogenic bacteria are found in anaerobic environments where electron acceptors are at a premium, the ability of acetogens to use CO 2 as an electron acceptor via the WLP, gives them a competitive advantage. In addition, the majority of acetogens are able to use many different electron acceptors and electron donors, making them good at adapting to the energy and redox requirements of their environment. In addition to harboring the genes for the WLP, most acetogens have membrane bound hydrogenases that are able to interconvert their reducing equivalents in an electron transport chain. One of the best-characterized examples is the Rhodobacter nitrogen fixation (RNF) complex originally characterized in an electron transporter associated with nitrogenases [40] . The RNF complex, found in numerous strains of acetogens, couples the oxidation of Fd to the reduction in pyridine nucleotides with the generation of either a Na + or H + membrane gradient (Fig. 2) . This process is reversible and can help cycle reducing equivalents between various electron carriers. The membrane gradient produced by the RNF complex can then be utilized to generate additional ATP, coupling acetogenesis to an ATP-generating process in the cell or membrane transport of substrates. However, not all acetogens harbor RNF complexes, although those that do not usually encode some membrane-bound energy conserving hydrogenase system capable of interconverting reducing equivalents whilst generating a membrane ion gradient [41] . The largest group of characterized acetogens present in mammalian gut microbiomes is found in the Firmicutes phylum. However, unlike methanogenesis and sulfidogenesis, the acetogenesis phenotype has also been identified in other phyla, making acetogens a more diverse group of H 2 utilizers [42] . Studies have shown that in humans, acetogenesis during glucose fermentation by gut microbes contributes to up to a third of the total amount of acetate produced [42] . As acetogens are a heterogenous group of bacteria, traditional means of 16S screening are not effective, but some studies have screened genes from the acetogenic WLP pathway in stool samples and have found them at levels of 10 3 -10 7 genesÁg À1 stool. In vivo data suggest that acetogens are the most abundant potential H 2 utilizers present in the gut microbiome [42] . Hence, these observations suggest that acetogenic utilization of H 2 in the colon may be the prevalent pathway of CO 2 reduction in humans that harbor neither active methanogens nor H 2 S producers.
Bile acid synthesis by the host
Under normal physiological conditions, microbial fermentation of complex carbohydrates and amino acids in the colon is quantitatively the most prevalent reactions occurring. However, other exogenous and endogenous molecules also enter the lumen of the large intestine where they become substrates for microbial biotransformations. One such group of molecules is bile acids, synthesized by hepatocytes from cholesterol in the liver. The two major bile acids produced in humans are cholic acid (3a, 7a, 12a-trihydroxy-5b-cholan-24-oic acid; CA) and chenodeoxycholic acid (3a, 7a-dihydroxy-5b-cholen-24-oic acid, CDCA (Fig. 3) . It is important to note that primary bile acid synthesis differs between vertebrates [48] . This is particularly important in the use of animals as models of human physiology and disease. In rodents, CDCA is converted mostly to the 6-hydroxylated derivative, b-muricholic acid (MCA), with minor amounts of a-MCA and ursodeoxycholic acid (UDCA) [48] . Taurob-MCA is a potent Farnesoid X receptor (FXR) antagonist [49] , but this bile acid is not found in humans. In contrast, the human liver does not express 6a/b hydroxylases nor a bile acid 7a-hydroxylase which allow secondary bile acid to accumulate in the bile acid pool of humans [46] . Recently, a wild-type mouse was genetically modified to eliminate the 6b-hydroxylase gene allowing these animals to synthesize predominantly taurine conjugates of CA and CDCA [50] .
Biotransformations of bile acids by gut bacteria
During enterohepatic circulation the first reaction bile salts undergo is deconjugation of their taurine or glycine conjugate by bile salt hydrolases (BSH) [46] . Typically the ratio of glycine : taurine conjugation in humans is 3 : 1; however, this is impacted by diet. It has been shown that individuals on a 'Western diet' have predominantly taurine conjugation, while individuals on a vegetarian diet shift toward glycine conjugation [51] . BSH activity is widely present in the microbes populating both the large and small intestines. Gram-positive commensal bacteria with BSH activity include: Clostridium, Enterococcus, Bifidobacterium, and Lactobacillus [46]. BSH activity is less widespread in commensal Gram-negative bacteria, but include members of the genus Bacteroides [46]. Gutassociated archaea M. smithii and Methanosphera stadmanae have also been found to have BSH activity [52] . BSH enzymes specifically hydrolyze the N-acyl bond on the 24th carbon that is responsible for linking the amino acid conjugate to the bile acid (Fig. 3) . Once bile acids are liberated from their conjugate, they become substrates for numerous microbial biotransformations. Bile acid 7a-dehydroxylation is a process by which a small group of gut bacteria within the genus Clostridium are able to remove the 7a or 7b-hydroxyl group from CA, CDCA, and UDCA forming secondary bile acids, deoxycholic acid (3a, 12a-dihydroxy-5b-cholen-24-oic acid; DCA) and lithocholic acid (3a-monohydroxy-5b-cholen-24-oic acid; LCA) respectively [46, 47] . Studies measuring fecal bile acid composition show that secondary bile acids form the major constituency, suggesting that the 7a-dehydroxylation pathway is the most quantitatively significant biotransformation of primary bile acids by gut microbes after BSH. In metagenomic analyses, Clostridium scindens, a well-characterized 7a-dehydroxylating species, has been shown to be a member of the 'core gut microbiome' in humans, due to its high rate of prevalence in human fecal samples [46, 47] . DCA, and to a smaller degree LCA, both passively diffuse across the epithelial barrier and enter portal circulation, where they are taken up by the liver and enter the circulating bile acid pool in humans [46] . Norman and Sj€ ovall were able to distinguish primary bile acids, made by the host, and secondary bile acids, made by commensal intestinal microbes [53] . In this earliest work of determining the pathway for microbial conversion of primary bile acids to secondary bile acids, it was proposed that the mechanism was a two-step process with a single intermediate, cholen-6-oic acid [54] . However, subsequent work by Hylemon et al. [55] showed metabolism of [24-14 C]-CA by cell extracts of C. scindens showed the formation of Members of the intestinal microbiota have genes that encode a variety of pyridine nucleotide-dependent bile acid hydroxysteroid dehydrogenases (HSDH). HSDHs are widely distributed throughout various members of the gut microbiota [47] . Gut microbes are known to be capable of oxidation and reduction in the hydroxyl groups on the 3-, 7-, and 12-carbons of bile acids (Fig. 3) . The epimerization of bile acid hydroxyl groups (a ↔ b) requires two position-specific bile acid a-and b-HSDHs, which generate a stable oxo-bile acid intermediate i.e., 7a-hydroxy ⟷ 7-oxo ⟷ 7b-hydroxy. Bacterial bile acid HSDHs differ in their pH optima, pyridine nucleotide specificity (NAD(H), NADP(H), or both), subunit molecular weight, and gene regulation [47] . Amino acid sequence analysis suggests that most bacterial HSDHs in the gut microbiota belong to the short-chain alcohol/polyol dehydrogenase family [56] [57] [58] . Bile acid HSDHs have been detected and characterized in numerous genera inhabiting the lumen of the colon, including; Bacteroides, Clostridium, Escherichia, Eggerthella, Eubacterium, Peptostreptococcus, and Ruminococcus [47, [56] [57] [58] .
Bile acids with oxidized hydroxyl groups (oxo-bile acids) have been shown to be present in fecal bile acids, portal circulation, and human serum [59, 60] . Interestingly, the hydroxyl groups on dihydroxy-bile acids (DCA, CDCA) have been shown to be more sensitive to microbial oxidoreductions than trihydroxybile acids (CA) [61] . The extent of epimerization and the accumulation of oxo-bile acids appears to be influenced by the oxidation/reduction potential of the local cellular environment. For example, the formation of oxo-bile acids may be more favorable in bacteria associated closer to the mucosal edges, where there is a higher redox potential than further inside the lumen of the intestines.
Consequences of bile acid metabolism on microbial and host physiology
To understand the effects of microbial biotransformations of bile acids on host and microbial physiology, it is important to first discuss the effects that bile acids have on normal host physiology. Near the turn of the millennium, it was discovered that endogenous bile acids were ligands for the orphan nuclear receptor FXR [62, 63] . Under normal physiological conditions, primary bile acids (CA and CDCA) activate FXR in enterocytes, leading to expression of fibroblast growth factor 15/19 (FGF15/19) [64, 65] . FGF15/19 then acts on the hepatic FGFR4 receptor in hepatocytes leading to down-regulation of CYP7A1, the rate-limiting enzyme of bile acid synthesis [64, 65] . Through this pathway, and the induction of SHP, bile acids are able to effectively inhibit their own synthesis.
Soon after the discovery of FXR activation by bile acids, it was shown that transmembrane Takeda G protein receptor 5 (TGR-5), a widely distributed receptor throughout human cells, is activated by bile acids [66] . TGR-5 is a Ga s receptor that leads to an increase in intracellular c-AMP. It has been reported that activation of TGR-5 can lead to the release of glucagonlike peptide 1 from specific intestinal cells, which has roles in glucose homeostasis as well as appetite suppression [67] . Subsequent work also showed that specific bile acids are ligands for pregnane-activated receptor (PXR) [68] , vitamin D receptor (VDR) [69] , sphingosine-1 phosphate receptor 2 [70] , and some muscarinic receptors (M 2,3 ) [71] .
While primary bile acids have been shown to be agonists for many different receptors, the potency of their activation differs based on their structures. In this regard, secondary bile acids have more potent agonist properties for specific nuclear receptors and G-protein coupled receptors, than primary bile acids. In the case of FXR, CDCA appears to be the most potent activator, but LCA and DCA are more potent than CA [62, 63] . Similarly, PXR appears to be most potently activated by LCA [68] , VDR by 3-oxo-LCA [69] , and TGR-5 by DCA and LCA [67] . Taken together, this suggests that not only can bile acids modulate the structure of the gut microbiome, but the microbes can also modulate host physiology by the creation of secondary bile acid 'hormones'.
Epimerization of the 7a-hydroxyl group on CDCA yields a much more hydrophilic and therefore less toxic metabolite UDCA [72] . Moreover, epimerization of the 3a-hydroxyl group of bile acid by specific gut bacteria also increases the hydrophilicity and decreases the toxicity toward gut bacteria [57] . Recent studies reported that 7-oxo-LCA acts as a competitive inhibitor of human hepatic 11b-HSDH-1 [73] . 11b-HSDH-1 is responsible for converting 7-oxo-LCA back to CDCA in the host; however, it also catalyzes the activation of cortisol from cortisone [74] . When 7-oxo-LCA is in high concentrations, it acts as a competitive inhibitor preventing production of active cortisol. The secondary bile acids 7-oxo-LCA and UDCA are both less potent agonists of FXR than CDCA [62, 63] .
Bile acid oxidation by Eggerthella lenta
It was reported in the 1970's that fecal isolates identified as Eggerthella lenta (formerly Eubacterium lentum) varied with respect to their capacity to oxidize bile acid hydroxyl groups. This led two independent labs to propose classification schemes for E. lenta isolates based on the number and type of hydroxysteroid dehydrogenase activities observed. On one end of the spectrum, E. lenta strains lacked observable bile acid HSDH activity, on the other end, strains were observed to express 3a, 7a, and 12a-HSDH as well as the bile acid epimerizing enzymes 3a and 3b-HSDH. Genes encoding the iso-bile acid pathway 3a-HSDH and 3b-HSDH have recently been reported in strains of E. lenta [57, 58] .
We recently reported genes encoding NADPHdependent 12a-HSDH in E. lenta DSM 2243 and from a metagenomic sequence, Eggerthella CAG:298 [58] Fig. 3 . The identity of genes encoding 7a-HSDH in E. lenta is still unknown, although reported in other gut bacteria such as C. scindens [56] , Escherichia coli, and Bacteroides fragilis [47] . Under strict anaerobic conditions (nitrogen atmosphere), we observed the complete conversion of primary and secondary bile acids to di-and tri-oxo derivatives, as well as the formation of small amounts of 3b-isomers. Intriguingly, when the gas atmosphere is replaced with hydrogen, bile acid oxidation is dramatically inhibited [75] .
We hypothesize that E. lenta couples bile acid oxidation to reductive acetogenesis. In support of this hypothesis, we observe a complete Rnf complex (rnfBAEGDC) in E. lenta DSM 2243 and strain C592 (Fig. 2) . The Rnf complex is a proton-translocating ferrodoxin : NAD + oxidoreductase which establishes a proton-motive force and conserves energy via H + -translocating ATPase under autotrophic conditions, using H 2 as an electron donor and CO 2 as electron acceptor [76] . We also observe several hydrogenases including NiFe Group 4e energy conserving hydrogenase and NiFe Group 1a [25] . It is typical of acetogens to bifurcate electrons from H 2 through FeFe hydrogenases, and it is not clear whether NiFe hydrogenases could participate in electron bifurcation. We observed genes in both the methyl branch and the carbonyl branch of the Wood-Ljundhal Pathway in the genome of E. lenta DSM 2243. Acetogens require acetyl-CoA synthase/carbon monoxide dehydrogenase, and these genes are located in a gene cluster (Elen_3026-3030) in E. lenta DSM 2243 [75] . We also observed that iso-CDCA is highly resistant to bile acid 7a-dehydroxylation by C. scindens as this bacterium does not have 3b-HSDH. Moreover, oxo-bile acids are also resistant to bile acid 7a-dehydroxylation [75] .
Conclusions and future directions
Much work remains to establish reductive acetogenesis in E. lenta or identify alternative mechanisms for the Fig. 4 . Regulation of bile acid metabolism by molecular hydrogen in the intestines. Under high levels of H 2 the bile acid 7a-dehydroxylating gut bacteria produce mostly secondary bile acids and the gut microbiota produce less iso and oxo bile acids. In contrast, under low H 2 more iso and oxo bile acid are formed by Eggerthella lenta decreasing bile acid 7a-dehydroxylation and altering the hydrophobic : hydrophilic balance of bile acid pool in the colon.
inhibition of bile acid oxidation by H 2 . Development of defined growth medium and genetic systems to manipulate the genome of Eggerthella will facilitate detailed mechanistic studies into the physiology of this important steroid metabolizing member of the Actinobacteria. The role of intestinal gas composition on bile acid metabolism has yet to be explored in vivo. Colonization of gnotobiotic animals with hydrogenproducers and bile acid metabolizing strains including E. lenta coupled with ingestible electronic gas sensors may provide a detailed understanding of the role of H 2 partial pressure on bile acid metabolism by E. lenta. The spatiotemporal distribution of E. lenta radially (mucosa to lumen), and the nature of bile acid oxidation with respect to oxygen gradients along this radial axis is another important aspect, as is whether there are significant changes longitudinally (Fig. 4) .
Colonic gas composition and concentration maybe an important regulation of the bile acid hydrophobichydrophilic balance in feces. In this regard, the conversion of primary to secondary bile acids increases the hydrophobicity of the colonic bile acid pool. In contrast, the oxidation of hydroxyl groups and the epimerization of hydroxyl groups, especially at carbons 3 and 7, markedly increases the hydrophilicity of the bile acid molecule. Colonic gas composition may play a role in regulating this physiological process. This has important implication for regulating the structure of the gut microbiome as hydrophobic bile acid are more toxic to bacteria than hydrophilic bile acids. Moreover, it has been recently been reported that bile acid 7a-dehydroxylating bacteria secrete tryptophan-derived antibiotics that are enhance by hydrophobic, but not hydrophilic bile acids (J. D. Kang, C. J. Myers, S. C. Harris, G. Kakiyama, I.-K. Lee 
